Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Thromboembolic Events”

322 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 322 results

Testing effectiveness (Phase 2)Study completedNCT01225822
What this trial is testing

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,973
Large-scale testing (Phase 3)UnknownNCT02503904
What this trial is testing

Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection

Who this might be right for
Surgical Site InfectionsVenous Thromboembolism
Klein, Jeffrey A., M.D. 400
Post-approval studies (Phase 4)Study completedNCT00182104
What this trial is testing

International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures

Who this might be right for
Heart DefectTriscupid Atresia
Hamilton Health Sciences Corporation 111
Large-scale testing (Phase 3)Study completedNCT00329238
What this trial is testing

Secondary Prevention of Venous Thrombo Embolism (VTE).

Who this might be right for
Thromboembolism
Boehringer Ingelheim 2,867
Large-scale testing (Phase 3)Study completedNCT06825416
What this trial is testing

A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Who this might be right for
Prevention of Arterial and Venous Thrombosis
Beijing Suncadia Pharmaceuticals Co., Ltd 1,166
Testing effectiveness (Phase 2)Study completedNCT00331838
What this trial is testing

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

Who this might be right for
Venous Thromboembolism
Sanofi 705
Testing effectiveness (Phase 2)Study completedNCT00320255
What this trial is testing

Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

Who this might be right for
ThrombosisCancerPulmonary Embolism
Bristol-Myers Squibb 130
Testing effectiveness (Phase 2)Study completedNCT02271399
What this trial is testing

Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Hanyang University Seoul Hospital 156
Large-scale testing (Phase 3)Looking for participantsNCT05920343
What this trial is testing

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Who this might be right for
Venous ThromboembolismUrologic Cancer
Ottawa Hospital Research Institute 120
Large-scale testing (Phase 3)Study completedNCT00937911
What this trial is testing

Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 101
Large-scale testing (Phase 3)Study completedNCT00423319
What this trial is testing

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Bristol-Myers Squibb 5,407
Testing effectiveness (Phase 2)Study completedNCT00402467
What this trial is testing

An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Who this might be right for
Venous Thromboembolism
Bayer 613
Testing effectiveness (Phase 2)Study completedNCT02048865
What this trial is testing

Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients

Who this might be right for
Venous ThromboembolismCancer
Ottawa Hospital Research Institute 575
Post-approval studies (Phase 4)Looking for participantsNCT02342444
What this trial is testing

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Who this might be right for
TraumaSurgeryDeep Vein Thrombosis (DVT)+1 more
Oregon Health and Science University 606
Not applicableStudy completedNCT04979780
What this trial is testing

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsProphylaxis of Recurrent Venous Thromboembolism in Cancer Patients
Bayer 3,708
Not applicableNot Yet RecruitingNCT06350344
What this trial is testing

Smart Technology Facilitated Patient-centered Venous Thromboembolism Management

Who this might be right for
Venous ThromboembolismDigital HealthHealth Education
Navy General Hospital, Beijing 2,353
Testing effectiveness (Phase 2)Study completedNCT00504556
What this trial is testing

Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

Who this might be right for
Atrial FibrillationThromboembolism
Daiichi Sankyo 1,146
Not applicableLooking for participantsNCT05628207
What this trial is testing

Evaluation of the SCALED (SCaling AcceptabLE cDs)

Who this might be right for
Traumatic Brain InjuryVenous Thromboembolism
University of Minnesota 15,000
Not applicableStudy completedNCT01139658
What this trial is testing

Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,676
Large-scale testing (Phase 3)Study completedNCT02066454
What this trial is testing

Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs

Who this might be right for
MyelomaVenous Thromboembolism
University Hospital, Grenoble 108
Load More Results